508 related articles for article (PubMed ID: 24439760)
1. Histopathology of streptococcus mitis/oralis endophthalmitis after intravitreal injection with bevacizumab: a report of 7 patients.
Matthews JL; Dubovy SR; Goldberg RA; Flynn HW
Ophthalmology; 2014 Mar; 121(3):702-8. PubMed ID: 24439760
[TBL] [Abstract][Full Text] [Related]
2. An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab.
Goldberg RA; Flynn HW; Isom RF; Miller D; Gonzalez S
Am J Ophthalmol; 2012 Feb; 153(2):204-208.e1. PubMed ID: 22264943
[TBL] [Abstract][Full Text] [Related]
3. Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results.
Goldberg RA; Flynn HW; Miller D; Gonzalez S; Isom RF
Ophthalmology; 2013 Jul; 120(7):1448-53. PubMed ID: 23453511
[TBL] [Abstract][Full Text] [Related]
4. An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone.
Sheyman AT; Cohen BZ; Friedman AH; Ackert JM
JAMA Ophthalmol; 2013 Jul; 131(7):864-9. PubMed ID: 23640384
[TBL] [Abstract][Full Text] [Related]
5. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
Fintak DR; Shah GK; Blinder KJ; Regillo CD; Pollack J; Heier JS; Hollands H; Sharma S
Retina; 2008; 28(10):1395-9. PubMed ID: 18827737
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.
Inoue M; Kobayakawa S; Sotozono C; Komori H; Tanaka K; Suda Y; Matsushima H; Kinoshita S; Senoo T; Tochikubo T; Kadonosono K
Ophthalmologica; 2011; 226(3):145-50. PubMed ID: 21811052
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
[TBL] [Abstract][Full Text] [Related]
8. The article by Fintak et al on the incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
El-Ashry MF; Dhillon B
Retina; 2009 May; 29(5):720-1; author reply 721-2. PubMed ID: 19430287
[No Abstract] [Full Text] [Related]
9. Incidence of Endophthalmitis after Intravitreal Bevacizumab using Aliquots Prepared On-site in 2 Operating Rooms in Kuwait.
Wani VB; Al-Kandari J; Sabti K; Aljassar F; Qali H; Kumar N; Uboweja A; Al-Sabah K; Diab FA; Al-Rashidi S
Middle East Afr J Ophthalmol; 2016; 23(1):64-70. PubMed ID: 26957841
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy.
Lima LH; Zweifel SA; Engelbert M; Sorenson JA; Slakter JS; Cooney MJ; Klancnik JM; Yannuzzi LA; Freund KB
Retina; 2009 Oct; 29(9):1213-7. PubMed ID: 19934815
[TBL] [Abstract][Full Text] [Related]
11. Onset of an outbreak of Bipolaris hawaiiensis fungal endophthalmitis after intravitreal injections of triamcinolone.
Small KW; Chan CK; Silva-Garcia R; Walsh TJ
Ophthalmology; 2014 Apr; 121(4):952-8. PubMed ID: 24507858
[TBL] [Abstract][Full Text] [Related]
12. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.
Cheung CS; Wong AW; Lui A; Kertes PJ; Devenyi RG; Lam WC
Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743
[TBL] [Abstract][Full Text] [Related]
13. Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.
Dossarps D; Bron AM; Koehrer P; Aho-Glélé LS; Creuzot-Garcher C;
Am J Ophthalmol; 2015 Jul; 160(1):17-25.e1. PubMed ID: 25892127
[TBL] [Abstract][Full Text] [Related]
14. Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection.
Chaudhary KM; Romero JM; Ezon I; Fastenberg DM; Deramo VA
Retina; 2013; 33(7):1407-16. PubMed ID: 23492945
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor.
Mezad-Koursh D; Goldstein M; Heilwail G; Zayit-Soudry S; Loewenstein A; Barak A
Retina; 2010; 30(7):1051-7. PubMed ID: 20616683
[TBL] [Abstract][Full Text] [Related]
16. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection.
Mason JO; White MF; Feist RM; Thomley ML; Albert MA; Persaud TO; Yunker JJ; Vail RS
Retina; 2008 Apr; 28(4):564-7. PubMed ID: 18398358
[TBL] [Abstract][Full Text] [Related]
17. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.
Moshfeghi AA; Rosenfeld PJ; Flynn HW; Schwartz SG; Davis JL; Murray TG; Smiddy WE; Berrocal AM; Dubovy SR; Lee WH; Albini TA; Lalwani GA; Kovach JL; Puliafito CA
Retina; 2011 Apr; 31(4):662-8. PubMed ID: 21836400
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
19. Acute intraocular inflammation caused by endotoxin after intravitreal injection of counterfeit bevacizumab in Shanghai, China.
Wang F; Yu S; Liu K; Chen FE; Song Z; Zhang X; Xu X; Sun X
Ophthalmology; 2013 Feb; 120(2):355-61. PubMed ID: 23084126
[TBL] [Abstract][Full Text] [Related]
20. Aggressive Surgical Therapy With Early Vitrectomy, Panretinal Photocoagulation, and Silicone Oil Tamponade for Streptococcus mitis Endophthalmitis.
Thomas BJ; Yonekawa Y; Ruby AJ; Capone A
Ophthalmic Surg Lasers Imaging Retina; 2015 Sep; 46(8):893-5. PubMed ID: 26431308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]